& Cornelis, S
GAPDH was used as a loading control on the same blot, or the same volumes were loaded from the same experimental sample
Standard research protocols of 4-8 weeks are well-characterized and often safe when properly conducted
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them: More common side effects acid or sour stomach belching constipation diarrhea stomach discomfort or upset Less common side effects bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site For healthcare professionals Applies to tirzepatide: subcutaneous solution